HOME
ABOUT
RESEARCH
PRODUCTS
INVESTORS
- ASX ANNOUNCEMENTS
  - 2021
  - 2020
  - 2019
  - 2018
  - 2017
  - 2016
- PRESENTATIONS & VIDEOS
  - 2021
  - 2020
  - 2019
  - 2018
  - 2017
  - 2016
  - 2015
- REPORTS
- STOCK INFORMATION
- CORPORATE GOVERNANCE
MEDIA
CONTACT

HOME
ABOUT
RESEARCH
PRODUCTS
INVESTORS
- - ASX ANNOUNCEMENTS
  - - 2021
  - - 2020
  - - 2019
  - - 2018
  - - 2017
  - - 2016
- - PRESENTATIONS & VIDEOS
  - - 2021
  - - 2020
  - - 2019
  - - 2018
  - - 2017
  - - 2016
  - - 2015
- - REPORTS
- - STOCK INFORMATION
- - CORPORATE GOVERNANCE
MEDIA
CONTACT

REPORTS

REPORTS

Sequoia Initiation Research Report, 19 August 2020 19/08/2020
Viriathus Research Report, 13 September 2018 24/01/2019

SUBSCRIBE

Leave this field empty if you're human:

Zelira TherapeuticsFollow

Zelira has released its most recent quarterly report for the 2021 financial year.

The Q4 highlights include strong growth on Q3 cash receipts (+38%), accelerating commercialisation and the achievement of significant research milestones.

Read more here:
http://ow.ly/xleR50FGLmK

Twitter 1420955741767208960

CONTACT US

Copyright © Zelira Therapeutics. All rights reserved. | Disclaimer.